Cumberland Pharmaceuticals
Utility Patents

Last updated:

List of all Cumberland Pharmaceuticals patents 4 in total

Status Patent
Grant
Utility: Compositions and methods of treating cardiac fibrosis with ifetroban External link
Filling date: 26 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Doses and methods for administering telavancin External link
Filling date: 26 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Compositions and methods of treating cardiac fibrosis with ifetroban External link
Filling date: 26 Sep 2025 Issue date: 10 Mar 2020
Grant
Utility: Compositions and methods of treating muscular dystrophy with thromboxane-A.sub.2 receptor antagonists External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2019

Showing 1 to 4 of 4 patents.